SANTEN PHARMACEUTICAL-UN ADR (SNPHY:OTCMKTS)

$12.03 0.3128 (2.6696%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 67

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed SANTEN PHARMACEUTICAL-UN ADR (SNPHY:OTCMKTS) News Sources

Glaucoma Global Clinical Trials Market Landscape Report 2025 Featuring Alcon, AbbVie, Santen Pharmaceutical, Pfizer, Kowa, Viatris, Merck, Novartis, Senju Pharmaceutical, Bausch Health

31-07-2025

yahoo.com

Saudi Arabia OTC Artificial Tears Market Forecast and Company Analysis Report 2025-2033 Featuring AbbVie, Akorn, Alcon, Bausch Health, J&J, Nicox, Novartis, Santen Pharmaceutical, Sun Pharmaceutical

07-08-2025

yahoo.com

RemeGen and Santen Enter into Exclusive Licensing Agreement for Ophthalmic Innovative Drug RC28-E in Greater China and Asian countries

19-08-2025

yahoo.com

Santen and RemeGen sign licence deal for retinal disease injection

19-08-2025

pharmaceutical-technology.com

Does Santen Share Price Reflect Its True Value After Recent Global Pharma Optimism in 2025?

15-09-2025

yahoo.com

Fuchs Endothelial Corneal Dystrophy Market Report 2025-2035: Bausch + Lomb, Santen Pharmaceutical, and Trefoil Therapeutics, Actively Shaping the Competitive Landscape

01-10-2025

yahoo.com

Koya Medical Honored by Goldman Sachs for Entrepreneurship

15-10-2025

yahoo.com

RVL Pharmaceuticals Announces Santen Obtains Manufacturing and Marketing Approval in Japan for UPNEEQ® Mini Ophthalmic Solution 0.1%

08-01-2026

yahoo.com

Faron Pharmaceuticals Ltd: Faron Appoints New CTO to Strengthen Late-Stage Development Activities

26-03-2026

yahoo.com

Assessing Santen Pharmaceutical (TSE:4536) Valuation After Recent Share Price Strength

28-03-2026

yahoo.com

SANTEN PHARMACEUTICAL-UN ADR (SNPHY:OTCMKTS) Sentiment Trend

0 25 50 75 100 68 66 71 79 83 84 63 50 53 57 31-07-2025 07-08-2025 19-08-2025 15-09-2025 01-10-2025 15-10-2025 08-01-2026 26-03-2026 28-03-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

SANTEN PHARMACEUTICAL-UN ADR (SNPHY:OTCMKTS) FAQs

toggle

What is the current price of SANTEN PHARMACEUTICAL-UN ADR (SNPHY:OTCMKTS)?

The current price of SANTEN PHARMACEUTICAL-UN ADR (SNPHY:OTCMKTS) is $12.03.


toggle

SANTEN PHARMACEUTICAL-UN ADR (SNPHY:OTCMKTS) absolute price change since previous trading day?

The absolute price change of SANTEN PHARMACEUTICAL-UN ADR (SNPHY:OTCMKTS) since the previous trading day is $0.3128.


toggle

SANTEN PHARMACEUTICAL-UN ADR (SNPHY:OTCMKTS) percentage price change since previous trading day?

The percentage price change of SANTEN PHARMACEUTICAL-UN ADR (SNPHY:OTCMKTS) since the previous trading day is 2.6696%.


toggle

What is the most recent average sentiment score for SANTEN PHARMACEUTICAL-UN ADR (SNPHY:OTCMKTS)?

The most recent average sentiment score for SANTEN PHARMACEUTICAL-UN ADR (SNPHY:OTCMKTS) is 67 out of 100.


toggle

What is the most recent average sentiment for SANTEN PHARMACEUTICAL-UN ADR (SNPHY:OTCMKTS)?

The most recent sentiment for SANTEN PHARMACEUTICAL-UN ADR (SNPHY:OTCMKTS) is .


SEC-8K** Filing Available For SANTEN PHARMACEUTICAL-UN ADR (SNPHY:OTCMKTS)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.